Ethosuximide

Back to search

Molecule Structure

Scientific Name

Ethosuximide

Description of the Drug

Ethosuximide is an anticonvulsant used to treat petit mal seizures.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00593

Brand Name(s)

Emeside, Ethosuximide, Suxinutin, Zarontin

Company Owner(s)

Parke Davis Div Warner Lambert Co, Strides Pharma Global Pte Ltd, Pharmaceutical Associates Inc, Mikart Llc, Teva Pharmaceuticals Usa, Puracap Pharmaceutical Llc, Bionpharma Inc, Heritage Pharmaceuticals Inc, Parke-Davis Division Of Pfizer Inc, Akorn Operating Co Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Voltage-gated T-type calcium channel PROTEIN FAMILY BLOCKER CHEMBL2362995

Unichem Links

SureChEMBL SCHEMBL20541518 SCHEMBL34212
PharmGKB PA449533
Human Metabolome Database HMDB0014731
DrugBank DB00593
PubChem: Thomson Pharma 15219092
PubChem 3291
Mcule MCULE-4034034545
LINCS LSM-5195
Nikkaji J1.477J
BindingDB 50240424
EPA CompTox Dashboard DTXSID7023019
DrugCentral 1087
Brenda 97926
ChemicalBook CB1420630
Guide to Pharmacology 7182
rxnorm ZARONTIN ETHOSUXIMIDE
PubChem: Drugs of the Future 57304373
KEGG Ligand C07505
ChEBI 4887